Clinical Trial Imaging Market To Reach $1.97 Billion By 2030

Clinical Trial Imaging Market Growth & Trends

The global clinical trial imaging market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

 Request a free sample copy or view report summary: Clinical Trial Imaging Market Report

Clinical Trial Imaging Market Report Highlights

• The project and data management services segment held the market with the largest revenue share of 28.73% in 2023 due to the growing requirement for data management and workflow for clinical trial imaging

• The operational imaging services segment also led the market with significant revenue share and are projected to grow the fastest CAGR of 7.32% from 2024 to 2030 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others

• The oncology segment held the market with the largest revenue share of 28.98% in 2023. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.

• The contract research organizations (CROs) segment led the market with the largest revenue share of 45.95% in 2023 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration

• North America dominated the market with a revenue share of 40.73% in 2023 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Clinical Trial Imaging Market Segmentation

 Grand View Research has segmented the clinical trial imaging market on the basis of on service, modality, application, end-use and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Trial Design and Consultation Services

• Reading and Analytical Services

• Operational Imaging Services

• System and Technology Support Services

• Project and Data Management

Clinical Trial Imaging Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Computed Tomography

• Magnetic Resonance Imaging

• X-Ray

• Ultrasound

• Optical Coherence Tomography (OCT)

• Others

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2018 - 2030)

• NASH

• CKD

• Diabetes

• Cardiovascular Diseases

• Ophthalmology

• Musculoskeletal

• Oncology

• Gastroenterology

• Pediatrics

• Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical companies

• Medical Devices Manufacturers

• Academic and Government Research Institutes

• Contract Research Organizations (CROs)

• Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • India

  • China

  • Japan

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Clinical Trial Imaging Market

• IXICO plc

• Navitas Life Sciences

• Resonance Health

• ProScan Imaging

• Radiant Sage LLC

• Medpace

• Biomedical Systems Corp

• Cardiovascular Imaging Technologies

• Intrinsic Imaging

• BioTelemetry